Related Articles
The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis
Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients
Clinical efficacy of the highly sensitive hepatitis C virus RNA quantitative assay in patients with relapse following interferon‑based therapy with second‑generation direct‑acting antivirals
Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection
Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group